Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis

NMR in Biomedicine

Volumn 13, Issue 5, 2000, Pages 271-288

  Bathen, Tone F ^a   Krane, Jostein ^a   Engan, Terje ^b,c   Bjerve, Kristian S ^b   Axelson, David ^d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d QUEEN S UNIVERSITY   (Canada)

Author keywords

Apolipoprotein; GMDH; GRNN; HDL; IDL; LDL; Lipid; Neural network; PLS; VLDL

Indexed keywords

APOLIPOPROTEIN; LIPID;

ADULT; AGED; ALGORITHM; ARTICLE; ARTIFICIAL NEURAL NETWORK; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MALE; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ASSAY;

EID: 0033846061     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1492(200008)13:5<271::AID-NBM646>3.0.CO;2-7     Document Type: Article

References (70)

1. Report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults. National Cholesterol Education Program. National Heart, Lung and Blood Institute
2. Associations of serum-lipid concentrations and obesity with mortality in women - 20 year follow-up of participants in prospective population study in Gothenburg, Sweden
3. Relationship between HDL-cholesterol and apolipoprotein A1 and the severity of coronary artery disease
4. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
5. Poor applicability of the Friedewald formula in the assessment of serum LDL cholesterol for clinical purposes
6. Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated
7. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary heart disease risk
8. Accurate direct determination of low-density lipoprotein cholesterol using an immunoseparation reagent and enzymatic cholesterol assay
9. Variability in cholesterol measurements: Comparison of calculated and direct LDL cholesterol determinations
10. Variability of lipid measurements: Relevance for the clinician
11. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol
12. National cholesterol education program recommendations for measurement of low-density lipoprotein cholesterol: Executive summary
13. National cholesterol education program recommendations for measurement of high-density lipoprotein cholesterol: Executive summary
14. National cholesterol education program recommendations for triglyceride measurement: Executive summary
15. Biological variability in concentrations of serum lipids: Sources of variation among results from published studies and composite predicted values
16. Within-person fluctuations of serum cholesterol and lipoproteins
17. 1H NMR spectroscopy of human blood plasma
18. A spectroscopic approach to lipoprotein subclass analysis
19. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy
20. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement
21. A comparative study of 1H NMR lineshape fitting analyses and biochemical lipid analyses of the lipoprotein fractions VLDL, LDL and HDL, and total human blood plasma
22. 1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma
23. 1H NMR data of human plasma
24. Lipoprotein-lipid quantification by neural-network analysis of 1H NMR data from human blood plasma
25. Quantification of plasma lipoprotein fractions by wavelet transform time-domain data processing of the proton nuclear magnetic resonance methylene spectral region
26. Quantification of lipids in the plasma lipoproteins VLDL, LDL and LDL with use of NMR and multivariate calibration
27. Pattern recognition approaches in biomedical and clinical magnetic resonance spectroscopy: A review
28. Apolipoprotein B and coronary artery disease in women: A cross-sectional study in women undergoing their first coronary angiography
29. 31P NMR spectra via principal component analysis: Potential and limitations
30. Spurious principal components in the set of spectra subjected to disturbances Presentation of the problem
31. The isolation and purification of plasma lipoproteins
32. Characterization of plasma lipids in patients with malignant disease by 13C nuclear magnetic resonance spectroscopy and gas liquid chromatography
33. Proton magnetic resonance spectroscopy of fractionated plasma lipoproteins and reconstituted plasma from healthy subjects and patients with cancer
34. Relationships between the proton nuclear magnetic resonance properties of plasma lipoproteins and cancer
35. Operating techniques in variable temperature experiments
36. Internal temperature calibration for 1H NMR spectroscopy studies of blood plasma and other biofluids
37. Assessment, validation and choice of calibration method
38. Genetic programming for classification and feature selection: Analysis of 1H nuclear magnetic resonance spectra from brain tumour biopsies
39. GRNN and bear it
40. A generalized regression neural network
41. Self-organizing Method in Modeling: GMDH Type Algorithms
42. 1H nuclear magnetic resonance spectroscopic data from human plasma
43. Spectroscopic calibration and quantitation using artificial neural networks
44. Data processing by neural networks in quantitative chemical analysis
45. 31P pig liver study
46. Computerized consensus diagnosis: A classification strategy for the robust analysis of MR spectra. Application to 1H spectra of thyroid neoplasms
47. In vivo proton MR spectroscopy of human gliomas: Definition of metabolic coordinates for multi-dimensional classification
48. 31P MR spectroscopy data
49. Automated feature extraction for the classification of human in vivo 13C NMR spectra using statistical pattern recognition and wavelets
50. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy
51. Towards a method for automated classification of 1H MRS spectra from brain tumours
52. Identification of the 1H-NMR spectra of complex oligosaccharides with artificial neural networks
53. Neural network based recognition of oligosaccharide 1H-NMR spectra
54. 1H magnetic resonance spectroscopic metabolite phenotypes
55. Structure investigation and proton and carbon-13 assignments of digitonin and cholesterol using multidimensional NMR techniques
56. Effects of orientational order and particle size on the NMR line positions of lipoproteins
57. NMR spectral quantitation by principal-component analysis II. Determination of frequency and phase shifts
58. Application of principal-component analysis for NMR spectral quantitation
59. Pattern recognition analysis of 1H NMR spectra from perchloric acid extracts of human brain tumor biopsies
60. Detection of malignant tumours by multivariate analysis of proton magnetic resonance spectra of serum
61. Introduction to the plasma lipoproteins
62. Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease
63. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness
64. Principal component analysis of proton nuclear magnetic resonance spectra of lipoprotein fractions from patients with coronary heart disease and healthy subjects
65. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease
66. Selection of samples for calibration in near-infrared spectroscopy. Part 1: General principles illustrated by example